PE13391A1 - Procedimiento de preparacion de derivados de piperazina - Google Patents
Procedimiento de preparacion de derivados de piperazinaInfo
- Publication number
- PE13391A1 PE13391A1 PE1990165681A PE16568190A PE13391A1 PE 13391 A1 PE13391 A1 PE 13391A1 PE 1990165681 A PE1990165681 A PE 1990165681A PE 16568190 A PE16568190 A PE 16568190A PE 13391 A1 PE13391 A1 PE 13391A1
- Authority
- PE
- Peru
- Prior art keywords
- preparation procedure
- piperazine derivative
- formula
- derivative preparation
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
SE REFIERE A LA PREPARACION DE COMPUESTOS DE FORMULA GENERAL I: CARACTERIZADO PORQUE SE HACE REACCIONAR UN ACIDO CARBOXILICO DE FORMULA (R2-CH2)n-COOH CON UNA PIPERAZINA DE FORMULA (II): EN MEDIO DE UN DISOLVENTE INERTE ADECUADO, COMO ETER ETILICO, TETRAHIDROFURANO DIOXANO O DIMETIL FORMAMIDA, EN PRESENCIA DE DCC. EN DONDE R1 ES TAL COMO UN RADICAL ALIFATICO INFERIOR DE HASTA 4 ATOMOS DE CARBONO; n=0, 1, 2 Y EN DONDE R2 ES TAL COMO 4-CLOROFENIL, 3-METILFENIL, 4-HIDROXIFENIL 4-FLUOROFENIL, ETC. DICHOS COMPUESTO SON UTILES COMO AGENTES ANALGESICOS Y ANTIINFLAMATORIOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89500021A EP0385043A1 (en) | 1989-02-28 | 1989-02-28 | New derivatives of 4-substituted piperazines |
Publications (1)
Publication Number | Publication Date |
---|---|
PE13391A1 true PE13391A1 (es) | 1991-04-17 |
Family
ID=8203081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1990165681A PE13391A1 (es) | 1989-02-28 | 1990-02-23 | Procedimiento de preparacion de derivados de piperazina |
Country Status (10)
Country | Link |
---|---|
US (1) | US5011928A (es) |
EP (1) | EP0385043A1 (es) |
JP (1) | JPH02288861A (es) |
AU (1) | AU636132B2 (es) |
CA (1) | CA2010750A1 (es) |
FI (1) | FI900963A0 (es) |
NO (1) | NO900934L (es) |
PE (1) | PE13391A1 (es) |
PT (1) | PT93276A (es) |
ZA (1) | ZA901449B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
ZA916555B (en) * | 1990-08-27 | 1993-04-28 | Lilly Co Eli | Method of treating inflammatory bowel disease |
EP0489690A1 (de) * | 1990-12-05 | 1992-06-10 | Ciba-Geigy Ag | Substituierte N-Benzoyl-N'-(2-phenylethyl)-piperazine |
ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
US5280046A (en) * | 1991-02-22 | 1994-01-18 | The University Of Colorado Foundation, Inc. | Method of treating type I diabetes |
EP0524146A1 (de) * | 1991-07-19 | 1993-01-20 | Ciba-Geigy Ag | Aminosubstituierte Piperazinderivate |
FR2680508B1 (fr) * | 1991-08-20 | 1995-03-03 | Adir | Nouveaux composes amidiques des 1-(alcoxybenzyl)piperazines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
US5830854A (en) * | 1992-12-14 | 1998-11-03 | Merck Sharp & Dohme, Limited | Method of treating cystic fibrosis using a tachykinin receptor antagonist |
US5384319A (en) * | 1993-01-06 | 1995-01-24 | Ciba-Geigy Corporation | Aminoalkylphenyl compounds |
US5380726A (en) * | 1993-01-15 | 1995-01-10 | Ciba-Geigy Corporation | Substituted dialkylthio ethers |
KR100342947B1 (ko) * | 1997-04-30 | 2002-08-22 | 주식회사 엘지씨아이 | 제초활성 아릴피페라진아미드 유도체 |
US6399618B1 (en) | 1997-07-09 | 2002-06-04 | Cardiome Pharma Corp | Compositions and methods for modulating sexual activity |
US6136807A (en) * | 1998-11-10 | 2000-10-24 | 3M Innovative Properties Company | Composition for the transdermal delivery of lerisetron |
EP1421071B1 (en) * | 2001-07-02 | 2009-11-18 | High Point Pharmaceuticals, LLC | Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
US7842693B2 (en) * | 2002-06-12 | 2010-11-30 | Chemocentryx, Inc. | Substituted piperazines |
US7589199B2 (en) | 2002-06-12 | 2009-09-15 | Chemocentryx, Inc. | Substituted piperazines |
US20050256130A1 (en) * | 2002-06-12 | 2005-11-17 | Chemocentryx, Inc. | Substituted piperazines |
US7157464B2 (en) | 2002-06-12 | 2007-01-02 | Chemocentryx, Inc. | Substituted piperazines |
WO2004002965A1 (de) * | 2002-06-29 | 2004-01-08 | Zentaris Gmbh | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen |
US7435831B2 (en) * | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
US7435830B2 (en) * | 2004-03-03 | 2008-10-14 | Chemocentryx, Inc. | Bicyclic and bridged nitrogen heterocycles |
RS59411B1 (sr) * | 2013-03-13 | 2019-11-29 | Forma Therapeutics Inc | Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodna jedinjenja kao inhibitori sintaze masnih kiselina (fasn) za lečenje kancera |
CN113382633A (zh) | 2018-10-29 | 2021-09-10 | 福马治疗股份有限公司 | (4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791501A (fr) * | 1971-11-19 | 1973-05-17 | Albert Ag Chem Werke | Diamines cycliques n,n'-disubstituees et leur procede de preparation |
JPS5346988A (en) * | 1976-10-07 | 1978-04-27 | Kyorin Seiyaku Kk | Piperadine derivative |
DE3139970A1 (de) * | 1981-10-08 | 1983-04-28 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
DE3276754D1 (en) * | 1981-12-02 | 1987-08-20 | Ferrosan Ab | 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them |
AU545463B2 (en) * | 1982-06-25 | 1985-07-18 | Kowa Co. Ltd. | Benzoyl piperacine esters |
US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
DE3602243A1 (de) * | 1985-06-13 | 1986-12-18 | Bayer Ag, 5090 Leverkusen | E-isomere von n(pfeil hoch)(alpha)(pfeil hoch)-(2-cyan-2-alkoximino-acetyl)-aminosaeurederivaten und -peptiden |
MY102447A (en) * | 1986-06-16 | 1992-06-30 | Ciba Geigy Ag | Disubtituted piperazines |
-
1989
- 1989-02-28 EP EP89500021A patent/EP0385043A1/en not_active Withdrawn
-
1990
- 1990-02-22 CA CA002010750A patent/CA2010750A1/en not_active Abandoned
- 1990-02-23 PE PE1990165681A patent/PE13391A1/es unknown
- 1990-02-26 FI FI900963A patent/FI900963A0/fi not_active IP Right Cessation
- 1990-02-26 ZA ZA901449A patent/ZA901449B/xx unknown
- 1990-02-27 NO NO90900934A patent/NO900934L/no unknown
- 1990-02-27 AU AU50166/90A patent/AU636132B2/en not_active Ceased
- 1990-02-28 PT PT93276A patent/PT93276A/pt not_active Application Discontinuation
- 1990-02-28 JP JP2049107A patent/JPH02288861A/ja active Pending
- 1990-02-28 US US07/486,098 patent/US5011928A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO900934L (no) | 1990-08-29 |
ZA901449B (en) | 1991-03-27 |
US5011928A (en) | 1991-04-30 |
FI900963A0 (fi) | 1990-02-26 |
NO900934D0 (no) | 1990-02-27 |
AU5016690A (en) | 1990-09-06 |
CA2010750A1 (en) | 1990-08-31 |
PT93276A (pt) | 1990-08-31 |
AU636132B2 (en) | 1993-04-22 |
JPH02288861A (ja) | 1990-11-28 |
EP0385043A1 (en) | 1990-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE13391A1 (es) | Procedimiento de preparacion de derivados de piperazina | |
IT1229570B (it) | Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
DK0484094T3 (da) | Azasteroide forbindelser til behandling af prostatahypertrofi, deres fremstilling og anvendelse | |
NO301542B1 (no) | Nye pyrazin-derivater | |
DK0474517T3 (da) | Hidtil ukendt anvendelse af 1alfa-hydroxyleret-19-nor-vitamin D- | |
DK0628569T3 (da) | Triterpenderivater og endothelinreceptorantagonister indeholdende samme | |
BR8902929A (pt) | Artigo vendavel | |
PT780372E (pt) | Derivados do acido 3-amino-2-mercaptobenzoico e processos para a sua preparacao | |
EA199800280A1 (ru) | Новые производные 5-0-дезозаминил-6-0-метилэритронолида а, способ их получения и их использование при получении биологически активных продуктов | |
KR910009259A (ko) | 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체 | |
ATE83772T1 (de) | Antihypercholesterolemische 4,5-diaryl-2substituierte thioimidazole. | |
ES543301A0 (es) | Cefalosporinas | |
HUT50464A (en) | Process for producing phenothiazin derivatives | |
DE3787844D1 (de) | Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen. | |
IE41831L (en) | W-(3`-benzoyl) phenyl-alkanoic or alkenoic acids. | |
IT1237529B (it) | Composti spiro-indolino-ossazine con caratteristiche fotocromatiche e fotosensibilizzatrici e procedimento per la loro preparazione | |
PE12891A1 (es) | Procedimiento para la preparacion de derivados de 4-piperidinalquilaminas | |
DE69108580D1 (de) | Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen. | |
SE8705187D0 (sv) | Novel aminoalkanoyl-dibenzo/d,g//1,3,6/dioxazocines and a process for the preparation thereof | |
ATE92461T1 (de) | Gegen die zerebrale insuffizienz wirksame verbindungen. | |
ES2037615B1 (es) | Procedimiento de preparacion de acido 1,1-dioxo penicilanico, de sus esteres y sales. | |
IT1253007B (it) | Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
ATE76865T1 (de) | Neue (meth)acrylsaeureester sowie deren verwendung. | |
NO167382C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer. | |
DE3766236D1 (de) | Dibenzo(be)oxepinessigsaeure-derivate, deren herstellung und therapeutische verwendung. |